Treatment-emergent mutations in myelodysplastic syndrome with del(5q) – lenalidomide related or disease-intrinsic clonal evolution?

Blood Cancer Journal, Published online: 18 March 2024; doi:10.1038/s41408-024-01027-5Treatment-emergent mutations in myelodysplastic syndrome with del(5q) – lenalidomide related or disease-intrinsic clonal evolution?

https://www.nature.com/articles/s41408-024-01027-5

Source: Blood Cancer Journal - March 18, 2024 Category: Hematology Authors: Mostafa Abdallah Kaaren Reichard Naseema Gangat Ayalew Tefferi Source Type: research

More News: Cancer | Cancer & Oncology | Hematology | Myelodysplastic Syndrome | Revlimid